• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IV期肛管鳞状细胞癌长期生存1例报告

Stage IV anal canal squamous cell carcinoma with long-term survival: a case report.

作者信息

Sawai Katsuji, Goi Takanori, Tagai Noriyuki, Kurebayashi Hidetaka, Morikawa Mitsuhiro, Koneri Kenji, Tamaki Masato, Murakami Makoto, Hirono Yasuo, Maeda Hiroyuki

机构信息

First Department of Surgery, University of Fukui, 23-3 Matsuoka Shimoaizuki Eiheiji-cho, Yoshidagun, Fukui, 910-1193, Japan.

Cancer Care Promotion Center, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuoka Shimoaizuki Eiheiji-cho, Yoshidagun, Fukui, 910-1193, Japan.

出版信息

Surg Case Rep. 2022 Jun 20;8(1):119. doi: 10.1186/s40792-022-01474-x.

DOI:10.1186/s40792-022-01474-x
PMID:35723765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9209564/
Abstract

BACKGROUND

Currently, no established standard treatment exists for metastatic anal squamous cell carcinoma. We report a case of complete response in a patient with stage IV anal squamous cell carcinoma after undergoing multidisciplinary treatment.

CASE PRESENTATION

A 62-year-old woman visited a nearby doctor with a chief concern of severe pain associated with a firm mass in the anus. The patient was diagnosed with anal canal squamous cell carcinoma and liver metastases and referred to First Department of Surgery Faculty of Medicine University of Fukui for treatment. The patient received a TNM classification of T4N0M1 and stage IV. Rectal amputation was performed; however, postoperative complications hindered immediate anticancer therapy and the liver metastases exacerbated. Radiofrequency hyperthermia and systemic chemotherapy were performed 3 months postoperatively. A prominent reduction in the liver metastasis was observed. Lung metastases appeared during the course of systemic chemotherapy. Radiotherapy was performed to treat the lung lesion and resolved. Radiotherapy was also performed for liver metastasis. The lesion in the liver showed resolution after 54 months postoperatively, and treatment with the anticancer drug was discontinued. Ten-year follow-up findings suggested complete resolution of the lesion in response to the treatment protocol followed in this case. This long-term survival was achieved through a multidisciplinary treatment.

CONCLUSIONS

The present case suggests that multidisciplinary treatment approach is effective for resolving stage IV anal squamous cell carcinoma, and addition of new anticancer drug therapy may improve the overall prognosis of squamous cell carcinoma.

摘要

背景

目前,转移性肛管鳞状细胞癌尚无既定的标准治疗方法。我们报告一例IV期肛管鳞状细胞癌患者在接受多学科治疗后完全缓解的病例。

病例介绍

一名62岁女性因肛门处有硬块并伴有剧痛前往附近医生处就诊。该患者被诊断为肛管鳞状细胞癌伴肝转移,并被转诊至福井大学医学部第一外科进行治疗。患者的TNM分期为T4N0M1,处于IV期。进行了直肠切除术;然而,术后并发症阻碍了立即进行抗癌治疗,且肝转移恶化。术后3个月进行了射频热疗和全身化疗。观察到肝转移明显缩小。在全身化疗过程中出现了肺转移。对肺部病变进行了放疗并得到缓解。也对肝转移进行了放疗。术后54个月肝脏病变显示消退,抗癌药物治疗停止。十年随访结果表明,按照本病例采用的治疗方案,病变完全消退。这种长期生存是通过多学科治疗实现的。

结论

本病例表明,多学科治疗方法对解决IV期肛管鳞状细胞癌有效,添加新的抗癌药物治疗可能改善鳞状细胞癌的总体预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1395/9209564/25e0569a1db7/40792_2022_1474_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1395/9209564/6f66339ffdb7/40792_2022_1474_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1395/9209564/cd287410b547/40792_2022_1474_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1395/9209564/26db3825f2dc/40792_2022_1474_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1395/9209564/ffbbbcdb3675/40792_2022_1474_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1395/9209564/633161f222fb/40792_2022_1474_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1395/9209564/e2b5ae7ce4b9/40792_2022_1474_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1395/9209564/25e0569a1db7/40792_2022_1474_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1395/9209564/6f66339ffdb7/40792_2022_1474_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1395/9209564/cd287410b547/40792_2022_1474_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1395/9209564/26db3825f2dc/40792_2022_1474_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1395/9209564/ffbbbcdb3675/40792_2022_1474_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1395/9209564/633161f222fb/40792_2022_1474_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1395/9209564/e2b5ae7ce4b9/40792_2022_1474_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1395/9209564/25e0569a1db7/40792_2022_1474_Fig7_HTML.jpg

相似文献

1
Stage IV anal canal squamous cell carcinoma with long-term survival: a case report.IV期肛管鳞状细胞癌长期生存1例报告
Surg Case Rep. 2022 Jun 20;8(1):119. doi: 10.1186/s40792-022-01474-x.
2
[A case of long-term survival in stage IV squamous cell carcinoma of the anal canal with multidisciplinary treatment].[1例肛管IV期鳞状细胞癌多学科治疗后的长期生存病例]
Nihon Shokakibyo Gakkai Zasshi. 2017;114(11):1987-1995. doi: 10.11405/nisshoshi.114.1987.
3
Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapy.传统放化疗治疗后疾病进展的难治性转移性肛管鳞状细胞癌的管理
J Adv Pract Oncol. 2012 May;3(3):161-9. doi: 10.6004/jadpro.2012.3.3.4.
4
Successful Management of Anal Squamous Cell Carcinoma With Liver and Ovary Metastases: A Case Report.成功治疗肝、卵巢转移肛门鳞癌 1 例报告
In Vivo. 2022 Nov-Dec;36(6):3023-3028. doi: 10.21873/invivo.13048.
5
Squamous cell carcinoma of the anus successfully treated with multidisciplinary therapy for metachronous metastatic and local recurrences after DCF chemotherapy: a case report.经多学科治疗成功治愈的肛门鳞状细胞癌:DCF化疗后异时性转移和局部复发的病例报告
Surg Case Rep. 2024 Mar 25;10(1):71. doi: 10.1186/s40792-024-01873-2.
6
[Squamous cell carcinoma of the anal canal showing complete response following chemoradiotherapy--a case report].[肛管鳞状细胞癌经放化疗后显示完全缓解——病例报告]
Gan To Kagaku Ryoho. 2007 Nov;34(12):2050-2.
7
[Effects of radical radiotherapy combined with different regimens of chemotherapy on radiation intestinal injury in patients with non-metastatic anal squamous cell carcinoma].[根治性放疗联合不同化疗方案对非转移性肛管鳞状细胞癌患者放射性肠损伤的影响]
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Nov 25;24(11):977-983. doi: 10.3760/cma.j.cn441530-20210810-00320.
8
[A case of a geriatric patient with stage IV anal canal cancer showing complete response to chemoradiation therapy].[一例老年肛管癌IV期患者对放化疗显示完全缓解的病例]
Gan To Kagaku Ryoho. 2012 Nov;39(12):1926-8.
9
Multimodal Therapy of Squamous Cell Carcinoma of the Anus With Distant Metastasis: A Single-Institution Experience.多模式治疗伴有远处转移的肛管鳞状细胞癌:单机构经验
Dis Colon Rectum. 2017 Aug;60(8):785-791. doi: 10.1097/DCR.0000000000000827.
10
Treatment strategy for vertebral metastases from anal squamous cell carcinoma: a comprehensive literature review and case report.肛门鳞癌椎体转移的治疗策略:全面文献回顾和病例报告。
Int J Neurosci. 2023 Dec;133(10):1124-1128. doi: 10.1080/00207454.2022.2052066. Epub 2022 Apr 3.

引用本文的文献

1
Cerebral metastasis from anal squamous cell carcinoma: A case report and literature review.肛管鳞状细胞癌脑转移:一例报告并文献复习
Oncol Lett. 2025 May 13;30(1):340. doi: 10.3892/ol.2025.15086. eCollection 2025 Jul.
2
Factors Influencing Outcomes and Survival in Anal Cancer.影响肛门癌结局和生存的因素。
Curr Oncol. 2024 Sep 2;31(9):5151-5163. doi: 10.3390/curroncol31090381.

本文引用的文献

1
Characteristics of anal canal cancer in Japan.日本肛门直肠癌的特征。
Cancer Med. 2022 Jul;11(14):2735-2743. doi: 10.1002/cam4.4631. Epub 2022 Mar 10.
2
Ten years and counting: Survival in stage IV metastatic squamous cell carcinoma of anal canal following radical treatment.十年及以上:根治性治疗后 IV 期转移性肛管鳞癌的生存情况。
J Cancer Res Ther. 2020 Dec;16(Supplement):S227-S229. doi: 10.4103/jcrt.JCRT_118_18.
3
Radiation Therapy for Uterine Cervical Cancer With Lung Metastases Including Oligometastases.宫颈癌伴肺转移包括寡转移的放射治疗。
In Vivo. 2019 Sep-Oct;33(5):1677-1684. doi: 10.21873/invivo.11655.
4
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.多西他赛、顺铂和氟尿嘧啶化疗治疗转移性或不可切除的局部复发性肛门鳞状细胞癌(Epitopes-HPV02):一项多中心、单臂、Ⅱ期研究。
Lancet Oncol. 2018 Aug;19(8):1094-1106. doi: 10.1016/S1470-2045(18)30321-8. Epub 2018 Jul 2.
5
Radiation generates an abscopal response and complete resolution of metastatic squamous cell carcinoma of the anal canal: a case report.放射治疗引发远隔效应并使肛管转移性鳞状细胞癌完全消退:一例报告
J Gastrointest Oncol. 2017 Dec;8(6):E84-E89. doi: 10.21037/jgo.2017.06.15.
6
Pharmacotherapy of Anal Cancer.肛门癌的药物治疗。
Drugs. 2017 Sep;77(14):1519-1530. doi: 10.1007/s40265-017-0792-3.
7
EGFR Inhibitors in Patients with Advanced Squamous Cell Anal Carcinomas: A Single-Institution Experience.表皮生长因子受体抑制剂治疗晚期肛管鳞状细胞癌患者:单机构经验
Oncology. 2017;92(4):190-196. doi: 10.1159/000452766. Epub 2017 Feb 3.
8
Successful hepatectomy for metastatic squamous cell carcinoma of the anal canal-a case report.肛管转移性鳞状细胞癌成功肝切除——病例报告
J Gastrointest Oncol. 2016 Dec;7(6):E103-E106. doi: 10.21037/jgo.2016.11.06.
9
Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).西妥昔单抗联合放化疗用于免疫功能正常的肛管癌患者:一项东部肿瘤协作组-美国放射学会影像网络癌症研究组的II期试验(E3205)
J Clin Oncol. 2017 Mar;35(7):718-726. doi: 10.1200/JCO.2016.69.1667. Epub 2017 Jan 9.
10
No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC).未发现鳞状细胞肛门癌 (SCAC) 中 NRAS 突变的证据。
Sci Rep. 2016 Nov 25;6:37621. doi: 10.1038/srep37621.